Effect of Nebivolol on MIBG Parameters and Exercise in Heart Failure with Normal Ejection Fraction.

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail (2012) 10.38

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J (2007) 10.38

Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med (1999) 7.59

ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol (1999) 4.71

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J (2005) 3.89

Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation (2010) 3.83

Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol (2010) 3.21

Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation (2006) 3.01

Development of a ventilatory classification system in patients with heart failure. Circulation (2007) 2.23

Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol (2009) 1.88

Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction. Circ Heart Fail (2014) 1.84

Impaired heart rate recovery and chronotropic incompetence in patients with heart failure with preserved ejection fraction. Circ Heart Fail (2009) 1.84

Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction--results of the Aldo-DHF trial. Int J Cardiol (2013) 1.56

Cardiopulmonary exercise testing variables reflect the degree of diastolic dysfunction in patients with heart failure-normal ejection fraction. J Cardiopulm Rehabil Prev (2010) 1.47

Cardiopulmonary exercise testing in the clinical and prognostic assessment of diastolic heart failure. J Am Coll Cardiol (2005) 1.20

Nebivolol: the somewhat-different beta-adrenergic receptor blocker. J Am Coll Cardiol (2009) 1.18

Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. Eur J Heart Fail (2011) 1.16

Functional consequences of endothelial nitric oxide synthase uncoupling in congestive cardiac failure. Circulation (2003) 1.07

The prognostic value of the heart rate response during exercise and recovery in patients with heart failure: influence of beta-blockade. Int J Cardiol (2008) 1.03

Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis. J Am Coll Cardiol (1999) 1.01

Heart failure with normal left ventricular ejection fraction: what is the evidence? Trends Cardiovasc Med (2008) 0.96

The role of obesity and obstructive sleep apnea in the pathogenesis and treatment of resistant hypertension. Curr Hypertens Rep (2014) 0.93

How to use myocardial 123I-MIBG scintigraphy in chronic heart failure. Eur J Nucl Med Mol Imaging (2009) 0.92

Hemodynamic determinants of the abnormal cardiopulmonary exercise response in heart failure with preserved left ventricular ejection fraction. J Card Fail (2012) 0.85

Systolic blood pressure response to exercise as a predictor of mortality in patients with chronic heart failure. Int Heart J (2010) 0.85

Iodine-123-metaiodobenzylguanidine imaging can predict future cardiac events in heart failure patients with preserved ejection fraction. Ann Nucl Med (2010) 0.84

Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure. Clin Interv Aging (2010) 0.81

Relationship between cardiac adrenergic image and exercise testing in heart failure. Arq Bras Cardiol (2011) 0.80

Effects of short-term carvedilol on the cardiac sympathetic activity assessed by 123I-MIBG scintigraphy. Arq Bras Cardiol (2010) 0.79

Nuclear cardiology and heart failure. Eur J Nucl Med Mol Imaging (2009) 0.78

The relationship between variables of 123-I-metaiodobenzylguanidine cardiac imaging and clinical status of the patients with diastolic heart failure. Int J Cardiol (2005) 0.78

Neuronal dysfunction and medical therapy in heart failure: can an imaging biomarker help to "personalize" therapy? J Nucl Med (2015) 0.77

Chronotropic and neurohumoral markers for the evaluation of functional capacity in patients with impaired left ventricular function. Hellenic J Cardiol (2008) 0.77

Assessment of aerobic capacity in overweight young females: A cross-sectional study. Int J Appl Basic Med Res (2015) 0.77

Clinical usefulness of myocardial innervation imaging using Iodine-123-meta-iodobenzylguanidine scintigraphy in evaluating the effectiveness of pharmacological treatments in patients with heart failure: an overview. Eur Rev Med Pharmacol Sci (2013) 0.76